1/19/2023 – Avivagen Announces Foundational Scientific and Commercial Evidence of OxC-Beta(TM) Product Published in Peer-Reviewed Journal

10/31/2022 – Avivagen Inc. Announces Closing of Second Tranche of a Private Placement of Shares